Unknown

Dataset Information

0

Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.


ABSTRACT: The active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (calcitriol) has antiproliferative effects in non-aggressive prostate cancer, however, its effects in more aggressive model systems are still unclear. In these studies, effects of calcitriol and a less-calcemic vitamin D analog, QW-1624F2-2 (QW), were tested in vivo, using the aggressive autochthonous transgenic adenocarcinoma of mouse prostate (TRAMP) model. To study prevention of androgen-stimulated prostate cancer, vehicle, calcitriol (20 µg/kg), or QW (50 µg/kg) were administered to 4 week-old TRAMP mice intraperitoneal (i.p.) 3×/week on a MWF schedule for 14 weeks. Calcitriol and QW slowed progression of prostate cancer as indicated by reduced urogenital tract (p?=?0.0022, calcitriol; p?=?0.0009, QW) and prostate weights (p?=?0.0178, calcitriol; p?=?0.0086, QW). However, only calcitriol increased expression of the pro-differentiation marker, cadherin 1 (p?=?0.0086), and reduced tumor proliferation (p?=?0.0467). By contrast, neither vitamin D analog had any effect on castration resistant prostate cancer in mice treated pre- or post-castration. Interestingly, although vitamin D showed inhibitory activity against primary tumors in hormone-intact mice, distant organ metastases seemed to be enhanced following treatment (p?=?0.0823). Therefore, TRAMP mice were treated long-term with calcitriol to further examine effects on metastasis. Calcitriol significantly increased the number of distant organ metastases when mice were treated from 4 weeks-of-age until development of palpable tumors (20-25 weeks-of-age)(p?=?0.0003). Overall, data suggest that early intervention with vitamin D in TRAMP slowed androgen-stimulated tumor progression, but prolonged treatment resulted in development of a resistant and more aggressive disease associated with increased distant organ metastasis.

SUBMITTER: Ajibade AA 

PROVIDER: S-EPMC3935875 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.

Ajibade Adebusola Alagbala AA   Kirk Jason S JS   Karasik Ellen E   Gillard Bryan B   Moser Michael T MT   Johnson Candace S CS   Trump Donald L DL   Foster Barbara A BA  

PloS one 20140226 2


The active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (calcitriol) has antiproliferative effects in non-aggressive prostate cancer, however, its effects in more aggressive model systems are still unclear. In these studies, effects of calcitriol and a less-calcemic vitamin D analog, QW-1624F2-2 (QW), were tested in vivo, using the aggressive autochthonous transgenic adenocarcinoma of mouse prostate (TRAMP) model. To study prevention of androgen-stimulated prostate cancer, vehicle, calcitr  ...[more]

Similar Datasets

2015-03-02 | E-GEOD-57382 | biostudies-arrayexpress
| S-EPMC4123218 | biostudies-literature
2015-03-02 | GSE57382 | GEO
| S-EPMC4549392 | biostudies-literature
| S-EPMC3165145 | biostudies-literature
| S-EPMC4170603 | biostudies-literature
| S-EPMC2815187 | biostudies-literature
| S-EPMC2747670 | biostudies-literature
| S-EPMC3471149 | biostudies-literature
| S-EPMC4259248 | biostudies-literature